JLJohn Samuel Leeds

John Samuel Leeds

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


John Samuel Leeds has a total of 275 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Post-ERCP persistent hepatocellular secretory failure: clinical profile, biochemical correlates and implications for management strategies

    by Eyad Gadour, Syed Anjum Gardezi, Shyam Vedantam, Abdullah Alotaibi, Umair Kamran, John Leeds, Saqib Ahmad, Shanil Kadir, Ben Maher, Mark Wright, et al.

    Objective: Persistent hepatocellular secretory failure (PHSF) is a rare condition marked by sustained hyperbilirubinaemia despite successful biliary decompression in patients with biliary obstruction. This study aimed to characterise postendoscopic retrograde cholangiopancreatography (ERCP) PHSF and its clinical course. Methods: This multicentre retrospective case series included adults with bilirubin >10 mg/dL persisting at least 1 week after ERCP biliary decompression. Data were collected from collaborating tertiary referral sites from January 2015 to January 2021. Exclusion criteria included chronic liver disease, recent hepatotoxic exposure, hepatic malignancy or liver metastasis. The primary aim was to describe the epidemiological and clinical characteristics of post-ERCP PHSF; secondary aims were to identify clinical and biochemical correlates of the degree of persistent hyperbilirubinaemia. Results: Thirty-five patients (mean age 65.2 years) were analysed: 25 with pancreatic head mass/distal obstruction and 10 with choledocholithiasis. Mean bilirubin decreased from 27.3±11.9 mg/dL pre-index ERCP to 21.1±9.3 mg/dL pre-second ERCP (p=0.0003). Pre-index ERCP bilirubin was associated with pre-second ERCP bilirubin (R 2 =0.43, p<0.001). Alkaline phosphatase (p=0.0002), platelet count (p=0.04) and time from symptom onset to index ERCP (p<0.001) correlated with pre-second ERCP bilirubin. Patients with self-expanding metal stents (SEMS) had higher pre-second ERCP bilirubin than those with DC (25.4 vs 13.2 mg/dL, p=0.0008). Further intervention during the second ERCP did not significantly reduce the time to halve the bilirubin level (p=0.80). Conclusion: Post-ERCP PHSF may persist despite adequate biliary decompression. The findings support careful exclusion of mechanical obstruction while recognising that repeat ERCP intervention may not accelerate bilirubin clearance in patients meeting PHSF criteria. Prospective studies are required to validate diagnostic pathways and evaluate targeted pharmacological therapy.

  • Open Access

    From ambition to delivery: why realistic research matters in UK gastroenterology and hepatology

    by Vishal C Patel, Debbie L Shawcross, John S Leeds, Lynsey Corless

  • Open Access

    Reverse rendezvous endoscopic retrograde cholangiopancreatography after liver partition and portal vein ligation

    by Khurum Hakeem, Eoin Keating, Khalid Bashir, Umair Kamran, Yiannis Skarparis, Dhya Al-Leswas, John Leeds

    A 45-year-old-man was diagnosed with primary rectal cancer during colonoscopy. Despite the initial disease response to neoadjuvant chemotherapy, imaging demonstrated progression of the right hepatic metastatic disease. Associated liver partition and portal ligation surgery (ALPPS) was planned. Stage 1 ALPPS was successful but extended hepatectomy and stage 2 ALPPS was complicated by a liver remnant anchor failure requiring repeat surgical intervention. High outputs from the right liver bed drain and cross-sectional imaging identified a liver bed bile leak secondary to a left hepatic duct stricture. Conventional endoscopic retrograde cholangiopancreatography (ERCP) was unable to access the intrahepatic system due a blind-ending proximal common bile duct (CBD).[1] Subsequent percutaneous transhepatic cholangiography (PTC) drainage accessed the left intrahepatic duct but could not traverse the stricture to the CBD. Multidisciplinary team discussion recommended a “reverse-rendezvous ERCP” to attempt internal drainage ([Video 1]).[2] [3] Initial CBD cannulation and pressure cholangiograms demonstrated persistent occlusion of the proximal CBD. Anterograde cholangiogram via the PTC demonstrated no communication of the intrahepatic ducts with the CBD, with a transition zone at the left hepatic duct. Video 1 Reverse rendezvous ERCP for postoperative bile leak after ALPPS. Endoscopic and percutaneous guidewires were advanced into the liver bed collection, creating through-and-through access from the ampulla to the left intrahepatic ducts. Following balloon dilatation, a plastic stent was placed for internal drainage, with contrast confirming flow into the duodenum. Endoscopic wire manipulation and occlusion cholangiography successfully accessed the left liver bed collection. Simultaneous percutaneous guidewire manipulation resulted in both wires entering the collection. A snare was deployed via the PTC and captured the endoscopic guidewire. This created a through-and-through guidewire crossing the ampulla, traversing the left intrahepatic duct and exiting the PTC site ([Fig. 1]). The tract was dilated by a 6 mm dilatation balloon. A 10 French×15 cm straight plastic stent was deployed entering the left intrahepatic ductal system. A PTC drain was deployed “kissing” the proximal CBD stent. PTC contrast injection demonstrated flow entering the duodenum. Four weeks following the initial rendezvous procedure, the drain was successfully internalised via the mature tract. This case represents the first published “reverse-rendezvouz ERCP” in a patient with unique post-operative biliary anatomy. Endoscopy_UCTN_Code_CPL_1AK_2AD. Received: 30 March 2026 Accepted after revision: 28 May 2026 Article published online: 13 July 2026 © 2026. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/). Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany

  • Open Access

    British Society of Gastroenterology interim technical review and position on the use of lumen apposing metal stents during therapeutic endoscopic ultrasound following the urgent medical device recall of the AXIOS stent and electrocautery enhanced delivery system

    by Matthew T Huggett, Manu Nayar, John Leeds, Neil O’MOrain, Pradeep Bhandari, Simon M Everett

    Background On 20 December 2025, Boston Scientific initiated an urgent field safety notice and recall of selected Hot AXIOS lumen-apposing metal stent (LAMS) systems (6×8 mm, 8×8 mm and 20×10 mm) following reports of deployment and expansion failures at the time of delivery. These devices are widely used in the UK for therapeutic endoscopic ultrasound (T-EUS), including pancreatic fluid collection (PFC) drainage, EUS-guided gallbladder drainage (EUS-GBD), choledochoduodenostomy (EUS-CDD), gastrojejunostomy (EUS-GJ) and EUS-Directed transgastric endoscopic retrograde cholangio pancreatography (ERCP) (EDGE) procedures. The recall has immediate implications for urgent and complex interventions. Methods The British Society of Gastroenterology (BSG) Endoscopy Committee convened an expert working group comprising members of the committee and UK T-EUS leaders. Using evidence synthesised for the forthcoming BSG T-EUS Guidelines, the group developed consensus-based interim recommendations addressing alternative devices, technical strategies, salvage of stent maldeployment and governance measures. All recommendations achieved 100% agreement and were ratified by the BSG Endoscopy Committee. Results For PFC drainage and EUS-GBD, unaffected AXIOS sizes and alternative LAMS (eg, HOT SPAXUS, Z-EUS) remain viable options, with plastic stents or percutaneous approaches as adjuncts. The greatest impact is in malignant distal biliary obstruction, where withdrawal of 6×8 mm and 8×8 mm devices necessitates consideration of 10×10 mm LAMS in selected cases, alternative LAMS, tubular self-expanding metal stents, EUS-rendezvous, EUS-guided hepaticogastrostomy or antegrade stenting. For EUS-GJ and EDGE, the use of smaller LAMS or staged techniques is advised. Practical guidance for recognition and rescue of LAMS maldeployment is summarised, alongside recommendations for enhanced governance, regional collaboration and prospective data capture. Conclusion This interim BSG position statement provides pragmatic, consensus-driven guidance to maintain safe and effective T-EUS practice in the UK following the AXIOS recall. These recommendations support clinical decision-making during this period of device limitation and complement forthcoming national guidelines.


  • Open Access

    Evaluation of a Novel Tapered Tip EUS-FNB Needle: A UK Multicentre Study

    by Darragh Storan, John Leeds, Arif Hussenbux, Mohamed Elseragy, Ruridh Allen, Tareq El Menabawey, Aaron McGowan, Matthew T. Huggett, Umair Kamran, Bidour Awadelkarim, et al.

    Introduction: A new core biopsy needle with a novel tapered stylet tip has been introduced for endoscopic ultrasound-guided fine needle biopsy (EUS-FNB). The tapered point stylet is purported to improve ease of puncture, leading to improved tissue acquisition and accuracy. However, there are no data available in the published literature. The aim of this study was to compare the diagnostic performance of the tapered stylet needle with conventional end-cutting FNB needles for tissue acquisition from solid lesions. Methods: Patients who underwent EUS-FNB of a solid lesion using the tapered stylet FNB needle across four tertiary hepatopancreaticobiliary centres in the UK were included in the study. Demographic, clinical, and performance outcomes were included in the analysis. Diagnostic performance was compared with a similar cohort of patients who underwent EUS-FNB using standard end-cutting FNB needles with a blunt-tipped stylet. The primary outcome was accuracy for the diagnosis of malignancy. Results: A total of 270 patients were included for analysis; 129 patients (48%) had sampling with the novel tapered stylet tip needle, among which 50% were female, the median age was 69, 74% had pancreatic lesions, and 80% had a final diagnosis of malignancy; 141 control cases (52%) were included for comparison, among which 48% were female, the median age was 68, 67% had pancreatic lesions, and 72% had a final diagnosis of malignancy. The tapered stylet needle demonstrated a sensitivity of 90% and an NPV of 72% for the diagnosis of malignancy compared with 88% and 77% for controls (p = 0.147). The overall diagnostic accuracy of the tapered stylet needle was 92.2% compared with 91.5% for controls (p = 0.634). Conclusions: The novel tapered tip stylet FNB needle demonstrated comparable sensitivity, NPV, and diagnostic accuracy to conventional FNB needles. This is the first and largest study reporting results for this new needle. However, further large comparative studies are warranted to validate our results and to determine if the tapered stylet offers an advantage over the conventional design.

  • EUS-guided gallbladder drainage with electrocautery-enhanced lumen-apposing metal stents: a UK and Ireland multicentre collaboration

    by James Gauci, Wafaa Ahmed, Bharat Paranandi, Wei On, John S Leeds, Matthew T Huggett

    Objective EUS-guided gallbladder drainage (EUS-GBD) with electrocautery-enhanced lumen-apposing metal stents (EC-LAMS) is an emerging method of establishing GBD in patients with acute cholecystitis lacking fitness for surgery. Robust data on long-term outcomes are lacking. This study assessed the efficacy, safety and durability of this procedure. Design/method Retrospective review of consecutive patients undergoing this procedure at 12 tertiary institutions across the UK and Ireland between January 2016 and May 2023 was undertaken. Primary outcomes included technical success, clinical success (resolution of acute cholecystitis within 96 hours) and adverse event (AE) rates at 30 days, 1 year and 3 years. Secondary outcomes in the cohort with non-malignant cholecystitis included rates of recurrent cholecystitis and further endoscopic procedures for stone extraction and/or stent removal. Results 64 patients (68.8% female) were included. The most common indication was calculous cholecystitis (45%; n=29) and the median follow-up period was 467 days. Technical and clinical success was achieved in 95.3% (n=61) and 94.6% (n=53), respectively. The 30-day AE rate was 4.7% (n=3). A further AE occurred in 15% (n=4), 7.1% (n=1) and 0% (n=0) at 1, 2 and 3 years, respectively, while the unplanned biliary reintervention rate was 0% (n=0), 7% (n=1) and 0% (n=0). Of those with benign disease, the EC-LAMS was removed in 15.0% (n=3) at 1 year, with only one case of recurrent cholecystitis. Conclusions EUS-GBD with EC-LAMS at tertiary institutions is a highly effective and relatively safe technique in patients who are not fit for surgery. Routine stent removal in non-malignant cases does not appear to impact clinical outcome.

  • Top Cited Papers

    Endoscopic ultrasound-guided tissue sampling: European Society of Gastrointestinal Endoscopy (ESGE) Technical and Technology Review

    by Antonio Facciorusso, Marianna Arvanitakis, Stefano Francesco Crinò, Carlo Fabbri, Adele Fornelli, John Leeds, Livia Archibugi, Silvia Carrara, Jahnvi Dhar, Paraskevas Gkolfakis, et al.

    This Technical and Technology Review from the European Society of Gastrointestinal Endoscopy (ESGE) represents an update of the previous document on the technical aspects of endoscopic ultrasound (EUS)-guided sampling in gastroenterology, including the available types of needle, technical aspects of tissue sampling, new devices, and specimen handling and processing. Among the most important new recommendations are:ESGE recommends end-cutting fine-needle biopsy (FNB) needles over reverse-bevel FNB or fine-needle aspiration (FNA) needles for tissue sampling of solid pancreatic lesions; FNA may still have a role when rapid on-site evaluation (ROSE) is available.ESGE recommends EUS-FNB or mucosal incision-assisted biopsy (MIAB) equally for tissue sampling of subepithelial lesions ≥20 mm in size. MIAB could represent the first choice for smaller lesions (<20 mm) if proper expertise is available.ESGE does not recommend the use of antibiotic prophylaxis before EUS-guided tissue sampling of solid masses and EUS-FNA of pancreatic cystic lesions.


  • Sequential comparison of two intraductal biliary brush cytology devices for suspected malignant biliary strictures

    by Manu Nayar, Kofi W Oppong, Pardeep Maheshwari, Sarah Johnson, Shiran Esmaily, Ruth Waller, John Leeds

    Background The diagnostic performance of endoscopic retrograde cholangiopancreatography brush cytology for malignant strictures is modest. A novel larger more abrasive brush may have improved diagnostic performance. We compared the utility of the new biliary brush with a conventional brush. Methods The new brush was used in 51 consecutive patients (group 1) referred with a biliary stricture and matched to 102 patients who underwent sampling with a conventional brush (group 2). Demographic data, stricture characteristics, sensitivity, specificity, negative predictive values and positive predictive values were analysed and compared with final diagnosis. Analysis was performed using strict criteria (definite for cancer) and relaxed criteria (suspicious for cancer). All patients had a minimum follow-up of 12 months. Results There was no statistically significant difference in the age and sex distribution between the two groups. Malignancy was diagnosed in 74% in both groups. There was no significant difference in sensitivity between the groups using either strict criteria (sensitivity group 1 47.4% vs group 2 52%, p=0.69) or relaxed criteria (sensitivity group 1 71.1% vs group 2 71.2%, p=1.0). Conclusions Our data suggest that the novel brush design does not confer improved diagnostic performance in malignant biliary strictures when compared in a robust manner. This highlights the difficulties of intraductal brush sampling and the need to develop newer diagnostic techniques.

  • Open Access

    Derivation, validation, and comparison of a new prognostic scoring system for acute lower gastrointestinal bleeding

    by Christopher Smith, Gillian Leggett, Anthoor Jayaprakash, Mohammed Khan, John M. Thomson, Balasubramaniam Vijayan, Andrew Fraser, John S. Leeds

    Objectives: Lower gastrointestinal bleeding is a common presentation with little data concerning risk factors for adverse outcomes. The aim was to derive and validate a scoring system to stratify risk in lower gastrointestinal bleeding and compare it to the Oakland score.Methods: A total of 2385 consecutive patients (mean age 65 years, 1140 males) were used to derive the score using multivariate logistic regression modeling then internally and externally validated. The Oakland score was applied and area under receiver operating characteristic (AUROC) curves were calculated and compared. A score of p = 0.009) but not mortality (0/365 vs. 1/355, p = 0.493).Conclusions: Our score predicts 30‐day rebleeding and mortality rate with low scores associated with very low risk. The Aberdeen score is superior to the Oakland score for predicting rebleeding. Prospective evaluation of both scores is required.